Evaluation of the hepatobiliary system in patients with paracoccidioidomycosis treated with cotrimoxazole or itraconazole
暂无分享,去创建一个
L. R. de Carvalho | D. Moris | R. Mendes | R. S. Cavalcante | Tatiane Fernanda Sylvestre | Adriele Dandara Levorato | Priscila Zacarias de Azevedo
[1] R. P. Mendes. The Gamut of Clinical Manifestations , 2018 .
[2] K. Sikaris,et al. The de ritis ratio: the test of time. , 2013, The Clinical biochemist. Reviews.
[3] K. Clements,et al. The Likelihood of Extinction of Iconic and Dominant Herbivores and Detritivores of Coral Reefs: The Parrotfishes and Surgeonfishes , 2012, PloS one.
[4] M. Felipe,et al. Genus Paracoccidioides: Species Recognition and Biogeographic Aspects , 2012, PloS one.
[5] Z. Zakaria,et al. Effects of Cytochrome P450 Inhibitors on Itraconazole and Fluconazole Induced Cytotoxicity in Hepatocytes , 2009, Journal of toxicology.
[6] Augusto Hasiak Santo,et al. Tendência da mortalidade relacionada à paracoccidioidomicose, Estado de São Paulo, Brasil, 1985 a 2005: estudo usando causas múltiplas de morte , 2008 .
[7] A. H. Santo. [Paracoccidioidomycosis-related mortality trend, state of São Paulo, Brazil: a study using multiple causes of death]. , 2008, Revista panamericana de salud publica = Pan American journal of public health.
[8] F. Queiroz-Telles,et al. An open-label comparative pilot study of oral voriconazole and itraconazole for long-term treatment of paracoccidioidomycosis. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[9] H. M. Khairi,et al. Involvement of Phenobarbital and SKF 525A in the Hepatotoxicity of Antifungal Drugs Itraconazole and Fluconazole in Rats , 2006, Drug and chemical toxicology.
[10] K. Brass. Observaciones sobre la Anatomía Patológica, Patogénesis y Evolución de la Paracoccidioidomicosis , 1969, Mycopathologia et mycologia applicata.
[11] Christopher Lawrence. Pathology , 1911, The Lancet.
[12] M. Sulaiman,et al. Hepatotoxicity induced by antifungal drugs itraconazole and fluconazole in rats: a comparative in vivo study , 2004, Human & experimental toxicology.
[13] B. Barraviera,et al. Evaluation of acetylator phenotype, renal function and serum sulfadiazine levels in patients with paracoccidioidomycosis treated with cotrimazine (a combination of sulfadiazine and trimethoprim) , 1989, Mycopathologia.
[14] B. Wanke,et al. Paracoccidioidomycosis mortality in Brazil (1980-1995). , 2002, Cadernos de saude publica.
[15] G. Benard,et al. Randomized trial with itraconazole, ketoconazole and sulfadiazine in paracoccidioidomycosis. , 2002, Medical mycology.
[16] D. Acosta,et al. N-deacetyl ketoconazole-induced hepatotoxicity in a primary culture system of rat hepatocytes. , 1997, Toxicology.
[17] M. Franco,et al. Host-parasite relationship in paracoccidioidomycosis. , 1995, Current topics in medical mycology.
[18] R. M. Tucker,et al. Adverse events associated with itraconazole in 189 patients on chronic therapy. , 1990, The Journal of antimicrobial chemotherapy.
[19] C. Bénichou. Criteria of drug-induced liver disorders. Report of an international consensus meeting. , 1990, Journal of hepatology.
[20] W. Maddrey,et al. Intrahepatic cholestasis and phospholipidosis associated with the use of trimethoprim‐sulfamethoxazole , 1990, Hepatology.
[21] Á. Restrepo,et al. Treatment of paracoccidioidomycosis with itraconazole. , 1990, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.
[22] K. Hostetler,et al. In vitro inhibition of lysosomal phospholipase A1 of rat lung by amiodarone and desethylamiodarone. , 1988, Biochimica et biophysica acta.
[23] A. Zauber,et al. Hematologic data of healthy very old people. , 1988, JAMA.
[24] Zauber Np,et al. Hematologic data of healthy very old people. , 1987 .
[25] M. Franco,et al. Host-parasite relationships in paracoccidioidomycosis. , 1987, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.
[26] Á. Restrepo,et al. Itraconazole in the treatment of paracoccidioidomycosis: a preliminary report. , 1987, Reviews of infectious diseases.
[27] R. Negroni,et al. Oral treatment of paracoccidioidomycosis and histoplasmosis with itraconazole in humans. , 1987, Reviews of infectious diseases.
[28] A. R. Tanner. Hepatic cholestasis induced by trimethoprim. , 1986, British medical journal.
[29] D. Grant,et al. Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity. , 1986, Annals of internal medicine.
[30] K. Hostetler,et al. Chloroquine-induced phospholipid fatty liver. Measurement of drug and lipid concentrations in rat liver lysosomes. , 1985, The Journal of biological chemistry.
[31] J. Horák,et al. Severe liver injuries due to sulfamethoxazole-trimethoprim and sulfamethoxydiazine. , 1984, Hepato-Gastroenterology.
[32] W. Dull,et al. Trimethoprim-Sulfamethoxazole-Induced Cholestatic Hepatitis: Inadvertent Rechallenge. , 1984, Archives of internal medicine.
[33] M. Døssing,et al. Drug-induced liver disease in Denmark. An analysis of 572 cases of hepatotoxicity reported to the Danish Board of Adverse Reactions to Drugs. , 1982, Scandinavian journal of gastroenterology.
[34] M. Ardiaca,et al. Trimethoprim-sulfamethoxazole-induced cholestasis. , 1981, The American journal of gastroenterology.
[35] D. Ransohoff,et al. Terminal hepatic failure following a small dose of sulfamethoxazole-trimethoprim. , 1981, Gastroenterology.
[36] L. Young,et al. Trimethoprim-sulfamethoxazole for the treatment of Pneumocystis carinii pneumonia. , 1980, Annals of internal medicine.
[37] L. Levine,et al. Trimethoprim-sulfamethoxazole-induced intrahepatic cholestasis. , 1980, Annals of internal medicine.
[38] T. Vree,et al. Pharmacokinetics of N1-Acetyl- and N4-Acetylsulphamethoxazole in Man , 1979, Clinical pharmacokinetics.
[39] H. Gelboin,et al. The Ah locus: genetic regulation of the metabolism of carcinogens, drugs, and other environmental chemicals by cytochrome P-450-mediated monooxygenases. , 1979, CRC critical reviews in biochemistry.
[40] F. Teixeira,et al. Morphological patterns of the liver in South American blastomycosis , 1978, Histopathology.
[41] C. Colucci,et al. Hepatic Necrosis and Trimethoprim-Sulfamethoxazole , 1975 .
[42] W. Brumfitt,et al. Trimethoprim-sulfamethoxazole in the treatment of bacteriuria in women. , 1973, The Journal of infectious diseases.
[43] K. Brass. [Observations on the pathologic anatomy, pathogenesis, and evolution of paracoccidioidomycosis]. , 1969, Mycopathologia et Mycologia Applicata.
[44] K. Salfelder,et al. Paracoccidioidomycosis. Anatomic study with complete autopsies. , 1969, Virchows Archiv. A, Pathology. Pathologische Anatomie.
[45] T. de Brito,et al. [Liver biopsy in South American blastomycosis]. , 1968, Revista do Instituto de Medicina Tropical de Sao Paulo.
[46] H. Zimmerman,et al. Sulfonamide hepatic injury. Review of the literature and report of a case due to sulfamethoxazole. , 1967, The New England journal of medicine.
[47] L. Böttiger,et al. Normal erythrocyte sedimentation rate and age. , 1967, British medical journal.
[48] Á. Campana,et al. [HEPATIC COMA IN SOUTH AMERICA BLASTOMYCOSIS]. , 1964, Revista da Associação Médica Brasileira.